Results for tag: "Oritavancin"

Oritavancin is an antibiotic used to treat serious skin and skin structure infections caused by Gram-positive bacteria. It is a lipoglycopeptide antibiotic, which is a type of antibiotic that works by inhibiting the formation of the bacterial cell wall. Oritavancin is administered as a single dose, making it an attractive option for patients who may not be able to take multiple doses of other antibiotics. It is also effective against a wide range of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The oritavancin market is a rapidly growing segment of the antibiotics market. It is expected to benefit from the increasing prevalence of Gram-positive infections, as well as the growing demand for single-dose antibiotics. The market is also expected to benefit from the increasing number of clinical trials and regulatory approvals for oritavancin. Some of the major companies in the oritavancin market include The Medicines Company, Allergan, Merck, and Pfizer. Show Less Read more